» Authors » Nigel Lewis

Nigel Lewis

Explore the profile of Nigel Lewis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 141
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Thompson L, Carr F, Rogers D, Lewis N, Charalampopoulos A, Fent G, et al.
Open Heart . 2024 Apr; 11(1). PMID: 38663890
Introduction: Heart failure (HF) incidence is increasing in older adults with high hospitalisation and mortality rates. Treatment is complicated by side effects and comorbidities. We investigated the clinical characteristics of...
2.
Knops R, El-Chami M, Marquie C, Nordbeck P, Quast A, Tilz R, et al.
Heart Rhythm . 2024 Feb; 21(6):836-844. PMID: 38336193
Background: The PRAETORIAN score estimates the risk of failure of subcutaneous implantable cardioverter-defibrillator (S-ICD) therapy by using generator and lead positioning on bidirectional chest radiographs. The PRospective randomized compArative trial...
3.
Lewis N, Leaptrot D, Witt E, Smith H, Hebden J, Wright M
Am J Infect Control . 2023 Apr; 51(10):1172-1174. PMID: 37120100
This case study is part of a series centered on the Centers for Disease Control and Prevention/National Healthcare Safety Network (NHSN) health care...associated infection surveillance definitions. This specific case study...
4.
Wolodimeroff E, Garg P, Swift A, Fent G, Lewis N, Rogers D, et al.
Open Heart . 2022 Jun; 9(1). PMID: 35649572
Objectives: We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised...
5.
Chinnappa S, Lewis N, Baldo O, Shih M, Tu Y, Mooney A
J Am Soc Nephrol . 2022 Feb; 32(7):1813-1822. PMID: 35138266
Background: Impaired exercise capacity is a significant symptom of CKD and is associated with poor survival. Furthermore, there is a growing interest in applying exercise as a diagnostic tool or...
6.
Vijapurapu R, Bradlow W, Leyva F, Moon J, Zegard A, Lewis N, et al.
Orphanet J Rare Dis . 2022 Jan; 17(1):6. PMID: 34991670
Background: Fabry disease (FD) is a treatable X-linked condition leading to progressive cardiac disease, arrhythmia and premature death. We aimed to increase awareness of the arrhythmogenicity of Fabry cardiomyopathy, by...
7.
Roy A, Umar H, Ochoa-Ferraro A, Warfield A, Lewis N, Geberhiwot T, et al.
J Clin Med . 2021 Oct; 10(19). PMID: 34640440
Fabry disease (FD) is a lysosomal storage disorder characterised by a deficiency in the enzyme α-galactosidase A resulting in sphingolipid deposition which causes progressive cardiac, renal, and cerebral manifestations. The...
8.
Mills M, Nelson T, Kelland N, Sahu J, Lee J, Lewis N, et al.
Eur Heart J Case Rep . 2021 Feb; 5(2):ytaa529. PMID: 33569526
Background: Cardiac involvement in Anderson-Fabry disease (AFD) can lead to arrhythmia, including ventricular tachycardia (VT). The literature on radiofrequency ablation (RFA) for the treatment of VT in AFD disease is...
9.
Fidock B, Archer G, Barker N, Elhawaz A, Al-Mohammad A, Rothman A, et al.
Int J Cardiol . 2021 Feb; 331:316-321. PMID: 33548381
Background: There are several methods to quantify mitral regurgitation (MR) by cardiovascular magnetic resonance (CMR). The interoperability of these methods and their reproducibility remains undetermined. Objective: To determine the agreement...
10.
Garg P, Dakshi A, Assadi H, Swift A, Naveed U, Fent G, et al.
Open Heart . 2021 Jan; 8(1). PMID: 33431617
Objectives: To characterise and risk-stratify patients presenting to a heart failure (HF) clinic according to the National Institute for health and Care Excellence (NICE) algorithm. Methods: This is an observational...